Biomet, Inc. Reschedules Fiscal Year 2009 First Quarter Release and Conference Call.

WARSAW, Ind. -- Biomet, Inc. announced today that it has rescheduled its Fiscal 2009 First Quarter release and first quarter conference call to Friday, October 10, 2008. The call will take place at 1:00 p.m. Eastern.

The dial-in numbers will remain the same. Individuals wishing to participate in the conference call may dial [phone]. International callers should dial [phone]. The confirmation number for the call is 4100270.

Biomet, Inc. and its subsidiaries design, manufacture, and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet's product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 90 countries.